Reports
Reports
Reference #:
Age: 64 years Gender: M Patient ID: 20231E0836155
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: Mar 24 2023 10:00
Telephone: (877) 849-3637
Reported on: Mar 24 2023 23:54 Toll Free: (877) 849-3637
Ordered by: SEGAL DR. PHILLIP Fax: (905) 795-9891
Copy To:
Test Flag Result Reference Range - Units Lab Lic. #
General Comments
#5687
Copy Not Sent Copy To physician was not uniquely identified.
General Chemistry
Glucose Fasting HI 7.3 3.6 - 6.0 mmol/L
Fasting Glucose greater than or equal to 7.0
mmol/L after an 8 hr fast can be used as a
provisional diagnosis of diabetes mellitus. If
asymptomatic, a repeat confirmation test using
Fasting Glucose, HbA1c, or 75g OGTT must be done.
Hemoglobin A1C/Total Hemoglobin HI 7.4 <6.0 %
Diabetes Canada 2018 Guidelines:
--------------------------------------------------
Screening and Diagnosis: < 5.5 % Normal
5.5% - 5.9 % At risk
6.0% - 6.4 % Prediabetes
>OR= 6.5 % Diabetes Mellitus
If HbA1c >OR= 6.5 % and asymptomatic, confirm
using Fasting Glucose, HbA1c or 75g OGTT.
--------------------------------------------------
Monitoring: <OR= 7.0 %
Target in adults without comorbidities. Other
targets may be more appropriate in children,
elderly and patients with comorbidities.
--------------------------------------------------
Results may not accurately reflect mean blood
glucose in patients with hemoglobin variants,
disorders associated with abnormal erythrocyte
turnover, severe renal and liver disorders.
Creatinine 76 67-117 umol/L
Glomerular Filtration Rate (eGFR) 92
Normal eGFR is described as greater than or equal
to 90 ml/min/1.73 m2.
Differential
Neutrophils 6.7 2.0 - 7.5 x E9/L
Lymphocytes 1.8 1.0 - 3.5 x E9/L
Monocytes 0.8 0.2 - 1.0 x E9/L
Eosinophils 0.3 0.0 - 0.5 x E9/L
Basophils 0.1 0.0 - 0.2 x E9/L
Immature Granulocytes 0.0 0.0 - 0.1 x E9/L
Nucleated RBC 0 /100 WBC
Bone Markers
25-Hydroxy Vitamin D LO 47.2 75.0 - 250.0 nmol/L
Vit D Deficiency: 25.0 - 74.9
Differential
Neutrophils 5.6 2.0 - 7.5 x E9/L
Lymphocytes 1.9 1.0 - 3.5 x E9/L
Monocytes 0.9 0.2 - 1.0 x E9/L
Eosinophils 0.2 0.0 - 0.5 x E9/L
Basophils 0.2 0.0 - 0.2 x E9/L
Nucleated RBC 0 /100 WBC
Metamyelocytes 0.0 x E9/L
Myelocytes 0.0 x E9/L
Promyelocytes 0.0 x E9/L
Blasts 0.0 x E9/L
Lymphocytes Variant 0.0 x E9/L
Plasma Cells 0.0 x E9/L
Leukocytes Other 0.0 x E9/L
Morphology
WBC Morphology NORMAL
RBC Morphology Slight Hypochromasia
Slight Microcytosis
Platelet Morphology NORMAL
Film held for Pathologist's report.
Pathologist Review --
Features of iron deficiency anemia. Low ferritin
level noted.
A. A. Erfaei M.D., Pathologist
General Chemistry
Glucose Fasting HI 7.1 3.6 - 6.0 mmol/L
Fasting Glucose greater than or equal to 7.0
mmol/L after an 8 hr fast can be used as a
provisional diagnosis of diabetes mellitus. If
asymptomatic, a repeat confirmation test using
Fasting Glucose, HbA1c, or 75g OGTT must be done.
#5687
Hemoglobin A1C/Total Hemoglobin HI 7.3 <6.0 %
Diabetes Canada 2018 Guidelines:
--------------------------------------------------
Screening and Diagnosis: < 5.5 % Normal
5.5% - 5.9 % At risk
6.0% - 6.4 % Prediabetes
>OR= 6.5 % Diabetes Mellitus
If HbA1c >OR= 6.5 % and asymptomatic, confirm
using Fasting Glucose, HbA1c or 75g OGTT.
--------------------------------------------------
Monitoring: <OR= 7.0 %
Target in adults without comorbidities. Other
targets may be more appropriate in children,
elderly and patients with comorbidities.
--------------------------------------------------
Results may not accurately reflect mean blood
glucose in patients with hemoglobin variants,
disorders associated with abnormal erythrocyte
turnover, severe renal and liver disorders.
#5407
Sodium 143 135-145 mmol/L
Potassium 4.7 3.5-5.2 mmol/L
Creatinine 67 67-117 umol/L
Glomerular Filtration Rate (eGFR) 97
Normal eGFR is described as greater than or equal
to 90 ml/min/1.73 m2.
Lipids
Hours After Meal Not Available Hours
Triglyceride 0.76 mmol/L
Cholesterol 2.66 mmol/L
HDL Cholesterol 1.18 mmol/L
New formulation (24/Sep/2018): In some patients
with abnormal liver function, the HDL-c result
may be different due to the presence of
lipoproteins with abnormal lipid distribution.
Non HDL Cholesterol 1.48 mmol/L
Non HDL-Cholesterol is not affected by the
fasting status of the patient.
LDL Cholesterol (Calculated) 1.13 mmol/L
LDL-C calculation is decreased if fasting
< or = 10 hours. Consider the Non HDL-C value as
an alternate lipid target if monitoring treatment
in intermediate or high risk patients.
Cholesterol/HDL Cholesterol 2.3
Lipid Target Values Lipid Target Values should be based on patient
10 year CVD risk assessment.
Thyroid Function
#5407
Thyroid Stimulating Hormone [TSH] 1.04 0.32-4.00 mIU/L
Tumour Markers
#5687
Prostate Specific Antigen 0.33 <4.0 ug/L
Methodology: Abbott Architect immunoassay.
Results should not be interpreted in isolation as
absolute evidence of the presence or absence of
malignant disease.
Changes in serial results may be misleading
unless all Total PSA results are from the same
laboratory method.
Prostate Specific Antigen Free 0.14 ug/L
Prostate Specific Antigen Free/Total Prostate 0.42
Specific Antigen
When Free/Total PSA ratio is <0.11, the
probability of prostate cancer is 44%-56%,
depending on the disease prevalence.
When Free/Total PSA ratio is >0.26 the
probability of prostate cancer is 11%-16%,
depending on the disease prevalence.
The interpretation guidelines above apply only
when the Total PSA is 4.0 to- 10.0 ug/L.
Bone Markers
#5407
25-Hydroxyvitamin D LO 39.4 75.0 - 250.0 nmol/L
Vit D Deficiency: 25.0 - 74.9
Differential
Neutrophils 6.8 2.0 - 7.5 x E9/L
Lymphocytes 1.7 1.0 - 3.5 x E9/L
Monocytes 0.9 0.2 - 1.0 x E9/L
Eosinophils 0.3 0.0 - 0.5 x E9/L
Basophils 0.1 0.0 - 0.2 x E9/L
Immature Granulocytes 0.0 0.0 - 0.1 x E9/L
Nucleated RBC 0 /100 WBC
Morphology
WBC Morphology NORMAL
RBC Morphology Few Elliptocytes/Ovalocytes
Slight Hypochromasia
Slight Microcytosis
Dual Population
Platelet Morphology NORMAL
Coagulation Studies
INR 1.1 0.9 - 1.2
Prothrombin Time
International Normalized Ratio Therapeutic Range
------------------------------------------------
Prophylaxis and treatment of
Thromboembolism 2.0 - 3.0
Differential
Neutrophils HI 7.9 2.0 - 7.5 x E9/L
Lymphocytes 1.4 1.0 - 3.5 x E9/L
Monocytes 1.0 0.2 - 1.0 x E9/L
Eosinophils 0.2 0.0 - 0.5 x E9/L
Basophils 0.1 0.0 - 0.2 x E9/L
Immature Granulocytes 0.0 0.0 - 0.1 x E9/L
Nucleated RBC 0 /100 WBC
Morphology
WBC Morphology Neutrophilia
RBC Morphology Slight Hypochromasia
Slight Microcytosis
Slightly increased Polychromasia
Dual Population
Platelet Morphology Increased slightly
Film held for Pathologist's report.
Pathologist Review --
Rule out iron deficiency anemia and chronic blood
loss. Consider serum ferritin and investigation
for blood loss. Neutrophilia - rule out
infection or inflammation. Thrombocytosis may be
reactive. Consider infection/inflammation or
hemorrhage.
A. A. Erfaei M.D., Pathologist